Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Aug 7, 2019 · 10-Q · 38 days after period end · 0001213900-19-014791
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Net Income | -$6.52M | -$2.85M | -$3.61M | -$2.24M |
| EPS Diluted | -$0.13 | -$0.06 | -$0.04 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 7, 2019 · 38 d after period end
